Aspartyl (asparaginyl) β-hydroxylase (AABH), a serum biomarker for lung cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.5_suppl.45
Abstract: 45Background: There are no serum biomarkers currently approved for the detection of lung cancer, a leading cause of cancer associated mortality world wide. More than 180,000 cases of lung cancer wi... read more here.
Keywords: asparaginyl hydroxylase; lung cancer; hydroxylase aabh; cancer ... See more keywords